Abstract
Pulmonary arterial hypertension is a major complication of systemic sclerosis. Although oxidative stress, intima hyperplasia and a progressive vessel occlusion appear to be clearly involved, the fine molecular mechanisms underpinning the onset and progression of systemic sclerosis-associated pulmonary arterial hypertension remain largely unknown. Here we shows for the first time that an increase of NADPH-derived reactive oxygen species production induced by sera from systemic sclerosis patients with pulmonary arterial hypertension drives collagen type I promoter activity in primary human pulmonary artery smooth muscle cells, suggesting that antioxidant-based therapies should be considered in the treatment of systemic sclerosis-associated vascular diseases.
Original language | English |
---|---|
Article number | 123 |
Pages (from-to) | 123 |
Number of pages | 5 |
Journal | Orphanet Journal of Rare Diseases |
Volume | 9 |
DOIs | |
Publication status | Published - 1 Aug 2014 |
Keywords
- Systemic sclerosis
- Pulmonary arterial hypertension
- Oxidative stress
- Vascular smooth muscle cells
- SYSTEMIC-SCLEROSIS
- DISEASE